THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0

作者：

Yamaoka, Kenji ^{[1
]}

Kawaoka, Tomokazu ^{[1
]}

Kosaka, Masanari ^{[1
]}

Johira, Yusuke ^{[1
]}

Shirane, Yuki ^{[1
]}

Miura, Ryoichi ^{[1
]}

Yano, Shigeki ^{[1
]}

Murakami, Serami ^{[1
]}

Amioka, Kei ^{[1
]}

Naruto, Kensuke ^{[1
]}

Ando, Yuwa ^{[1
]}

Kosaka, Yumi ^{[1
]}

Uchikawa, Shinsuke ^{[1
]}

Kodama, Kenichiro ^{[1
]}

Uchida, Takuro ^{[1
]}

Fujino, Hatsue ^{[1
]}

Ono, Atsushi ^{[1
]}

Nakahara, Takashi ^{[1
]}

Murakami, Eisuke ^{[1
]}

Okamoto, Wataru ^{[2
]}

Yamauchi, Masami ^{[1
]}

Miki, Daiki ^{[1
]}

Imamura, Michio ^{[1
]}

Chayama, Kazuaki ^{[3
]}

Aikata, Hiroshi ^{[1
]}

机构：

[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan

[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan

[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4508

引用

页码：S1386 / S1387

页数：2

共 50 条

[21] Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma [J].

Kawamura, Yusuke ;

Kobayashi, Masahiro ;

Shindoh, Junichi ;

Kobayashi, Yuta ;

Okubo, Satoshi ;

Tominaga, Licht ;

Kajiwara, Akira ;

Kasuya, Kayoko ;

Iritani, Soichi ;

Fujiyama, Shunichiro ;

Hosaka, Tetsuya ;

Saitoh, Satoshi ;

Sezaki, Hitomi ;

Akuta, Norio ;

Suzuki, Fumitaka ;

Suzuki, Yoshiyuki ;

Ikeda, Kenji ;

Arase, Yasuji ;

Hashimoto, Masaji ;

Kozuka, Tokuyo ;

Kumada, Hiromitsu .

LIVER CANCER, 2020, 9 (06) :756-770

[22] The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma [J].

Wen, Shilai ;

Zeng, Jingke ;

Zhong, Liting ;

Ye, Jianmin ;

Lai, Xiaohuan .

CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (11) :53-57

[23] Lenvatinib treatment for advanced hepatocellular carcinoma: The relationship between efficacy and safety [J].

Oikawa, T. ;

Yusa, K. ;

Okamoto, T. ;

Yonezawa, M. ;

Satou, T. ;

Abe, T. ;

Endo, K. ;

Sawara, K. ;

Kuroda, H. ;

Takikawa, Y. .

ANNALS OF ONCOLOGY, 2019, 30

[24] Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment [J].

Mizokami, Ken ;

Watanabe, Akiko ;

Yamaguchi, Eriko ;

Saito, Akira .

CASE REPORTS IN GASTROENTEROLOGY, 2022, 16 (02) :502-506

[25] Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis [J].

Yasuhiro Kawanishi ;

Michio Kuwahara ;

Masato Utsunomiya ;

Nobuko Ishida ;

Yoichi Ishikawa ;

Makoto Hiroi ;

Toyokazu Akimori .

Clinical Journal of Gastroenterology, 2021, 14 :288-292

[26] Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis [J].

Kawanishi, Yasuhiro ;

Kuwahara, Michio ;

Utsunomiya, Masato ;

Ishida, Nobuko ;

Ishikawa, Yoichi ;

Hiroi, Makoto ;

Akimori, Toyokazu .

CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) :288-292

[27] Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma [J].

Narita, Ryoichi ;

Kotoh, Kazuhiro ;

Yoneda, Akitoshi ;

Motomura, Mitsuteru ;

Harada, Masaru .

ANTICANCER RESEARCH, 2020, 40 (09) :5271-5276

[28] Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma? [J].

Oikonomopoulos, Georgios ;

Aravind, Preetha ;

Sarker, Debashis .

FUTURE ONCOLOGY, 2016, 12 (04) :465-476

[29] The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma [J].

Zhu, Jie ;

Fang, Peiqi ;

Wang, Chong ;

Gu, Meixiu ;

Pan, Baishen ;

Guo, Wei ;

Yang, Xinrong ;

Wang, Beili .

CANCER MEDICINE, 2021, 10 (22) :7977-7987

[30] Salvage Treatment of Nivolumab and Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma [J].

Zhou, Lijun ;

Peng, Wei ;

Duan, Huaxin ;

Deng, Tan .

HEPATITIS MONTHLY, 2023, 23 (01)

← 1 2 3 4 5 →